Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3908 participants
INTERVENTIONAL
2001-01-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There is growing evidence that vascular risk factors which are implicated in the etiology of stroke also play important etiologic roles in both vascular dementia and Alzheimer disease. The present project is aimed at the reduction of stroke and dementia by means of a systematic detection and subsequent treatment of vascular risk factors by the family doctor based on established guidelines.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Integrated Solution for Sustainable Care for Multimorbid Elderly Patients With Dementia
NCT05104593
Dementia and Kidney Disease: Epidemiological Approaches to Risk Factors and Treatment Strategies
NCT07093684
Safe & Easy for Alzheimer's Disease and Related Pathologies
NCT02518243
Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease
NCT01423396
Cognitive and Emotional Impairment After Stroke
NCT00506818
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Evidence-based treatment, lifestyle counseling
Systematic detection of vascular risk factors and subsequent evidence-based treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Systematic detection of vascular risk factors and subsequent evidence-based treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Member of a particular health insurance plan (AOK)
* Resident of the district of Ebersberg
Exclusion Criteria
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AOK Bayern
INDUSTRY
Stiftung Deutsche Schlaganfall-Hilfe
UNKNOWN
Ratiopharm GmbH
INDUSTRY
Sanofi-Synthelabo
INDUSTRY
Organon
INDUSTRY
Teva Pharma GmbH
INDUSTRY
Bayer
INDUSTRY
Berlin-Chemie Menarini
INDUSTRY
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dept. of Psychiatry, Technical University of munich
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Horst Bickel, PhD
Role: PRINCIPAL_INVESTIGATOR
Dept. of Psychiatry, Technical University of Munich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Depts. of Psychiatry and Neurology, Technische Universität München
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Scherpinski U, Bickel H, Gnahn H, Forstl H, Conrad B, Sander D. [Intervention project on cerebrovascular diseases and dementia in the Ebersberg district (INVADE): rationale and design]. Nervenarzt. 2002 Dec;73(12):1199-204. doi: 10.1007/s00115-002-1443-8. German.
Sander D, Schulze-Horn C, Bickel H, Gnahn H, Bartels E, Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke. 2006 Feb;37(2):351-7. doi: 10.1161/01.STR.0000199034.26345.bc. Epub 2005 Dec 22.
Sander K, Bickel H, Schulze Horn C, Huntgeburth U, Poppert H, Sander D. [Peripheral arterial disease: predictors and treatment intensity. Two-years of data from the population-based INVADE project]. Dtsch Med Wochenschr. 2008 Mar;133(10):455-9. doi: 10.1055/s-2008-1046731. German.
Bickel H, Block M, Gotzler O, Hartmann J, Purner K, Sander D, Forstl H. [Prevention of stroke and dementia in general practice: evaluation of the project INVADE]. Dtsch Med Wochenschr. 2020 Jun;145(12):e61-e70. doi: 10.1055/a-1124-9124. Epub 2020 Apr 16. German.
Bickel H, Ander KH, Bronner M, Etgen T, Gnahn H, Gotzler O, Poppert H, Purner K, Sander D, Forstl H. Reduction of Long-Term Care Dependence After an 8-Year Primary Care Prevention Program for Stroke and Dementia: The INVADE Trial. J Am Heart Assoc. 2012 Aug;1(4):e000786. doi: 10.1161/JAHA.112.000786. Epub 2012 Aug 24.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
080250hb
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.